25 XP   0   0   10

Inhalerx Ltd
Buy, Hold or Sell?

Let's analyse Inhalerx together

PenkeI guess you are interested in Inhalerx Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Inhalerx Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Inhalerx Ltd

I send you an email if I find something interesting about Inhalerx Ltd.

Quick analysis of Inhalerx (30 sec.)










What can you expect buying and holding a share of Inhalerx? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.02
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
A$-0.03
Return On Investment
-84.1%

For what price can you sell your share?

Current Price per Share
A$0.03
Expected price per share
A$0.03 - A$0.04
How sure are you?
50%

1. Valuation of Inhalerx (5 min.)




Live pricePrice per Share (EOD)

A$0.03

Intrinsic Value Per Share

A$-0.12 - A$-0.05

Total Value Per Share

A$-0.12 - A$-0.04

2. Growth of Inhalerx (5 min.)




Is Inhalerx growing?

Current yearPrevious yearGrowGrow %
How rich?$426.1k$1.2m-$792.3k-185.9%

How much money is Inhalerx making?

Current yearPrevious yearGrowGrow %
Making money-$924.2k-$1.2m$290.3k31.4%
Net Profit Margin0.0%-7,647.6%--

How much money comes from the company's main activities?

3. Financial Health of Inhalerx (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#305 / 340

Most Revenue
#335 / 340

Most Profit
#141 / 340

Most Efficient
#119 / 340

What can you expect buying and holding a share of Inhalerx? (5 min.)

Welcome investor! Inhalerx's management wants to use your money to grow the business. In return you get a share of Inhalerx.

What can you expect buying and holding a share of Inhalerx?

First you should know what it really means to hold a share of Inhalerx. And how you can make/lose money.

Speculation

The Price per Share of Inhalerx is A$0.031. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inhalerx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inhalerx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inhalerx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-15.7%0.00-15.7%-0.01-21.0%-0.01-17.6%-0.01-17.5%
Usd Book Value Change Per Share0.00-13.5%0.00-13.5%0.00-8.4%0.00-4.4%0.000.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-13.5%0.00-13.5%0.00-8.4%0.00-4.4%0.000.9%
Usd Price Per Share0.02-0.02-0.04-0.04-0.04-
Price to Earnings Ratio-3.81--3.81--5.91--7.97--6.98-
Price-to-Total Gains Ratio-4.45--4.45--14.69-1.13--1.37-
Price to Book Ratio8.27-8.27-5.98-10.02-7.49-
Price-to-Total Gains Ratio-4.45--4.45--14.69-1.13--1.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0198524
Number of shares50371
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (50371 shares)-210.32-68.58
Gains per Year (50371 shares)-841.28-274.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-841-8510-274-284
20-1683-16920-549-558
30-2524-25330-823-832
40-3365-33740-1097-1106
50-4206-42150-1372-1380
60-5048-50560-1646-1654
70-5889-58970-1920-1928
80-6730-67380-2195-2202
90-7572-75790-2469-2476
100-8413-84200-2743-2750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.05.00.037.5%3.05.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.05.00.037.5%3.05.00.037.5%

Fundamentals of Inhalerx

About Inhalerx Ltd

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-03-29 08:53:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Inhalerx Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Inhalerx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inhalerx Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-7,647.6%+7,647.6%
TTM-5Y-2,845.2%+2,845.2%
5Y-2,845.2%10Y-7,708.9%+4,863.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.2%+11.2%
TTM--19.6%+19.6%
YOY-7,647.6%-14.4%-7,633.2%
5Y-2,845.2%-21.3%-2,823.9%
10Y-7,708.9%-24.8%-7,684.1%
1.1.2. Return on Assets

Shows how efficient Inhalerx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • -91.5% Return on Assets means that Inhalerx generated $-0.92 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inhalerx Ltd:

  • The MRQ is -91.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -91.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-91.5%TTM-91.5%0.0%
TTM-91.5%YOY-84.0%-7.5%
TTM-91.5%5Y-126.2%+34.7%
5Y-126.2%10Y-92.9%-33.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-91.5%-4.0%-87.5%
TTM-91.5%-4.5%-87.0%
YOY-84.0%-4.8%-79.2%
5Y-126.2%-4.0%-122.2%
10Y-92.9%-5.2%-87.7%
1.1.3. Return on Equity

Shows how efficient Inhalerx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • -144.8% Return on Equity means Inhalerx generated $-1.45 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inhalerx Ltd:

  • The MRQ is -144.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -144.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-144.8%TTM-144.8%0.0%
TTM-144.8%YOY-99.7%-45.1%
TTM-144.8%5Y-206.1%+61.3%
5Y-206.1%10Y-144.9%-61.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-144.8%-3.9%-140.9%
TTM-144.8%-5.6%-139.2%
YOY-99.7%-5.9%-93.8%
5Y-206.1%-6.1%-200.0%
10Y-144.9%-7.1%-137.8%

1.2. Operating Efficiency of Inhalerx Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Inhalerx is operating .

  • Measures how much profit Inhalerx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inhalerx Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-7,756.7%+7,756.7%
TTM-5Y-2,599.5%+2,599.5%
5Y-2,599.5%10Y-1,758.6%-840.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--22.8%+22.8%
TTM--17.1%+17.1%
YOY-7,756.7%-13.4%-7,743.3%
5Y-2,599.5%-19.2%-2,580.3%
10Y-1,758.6%-24.0%-1,734.6%
1.2.2. Operating Ratio

Measures how efficient Inhalerx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inhalerx Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY78.958-78.958
TTM-5Y29.595-29.595
5Y29.59510Y18.623+10.972
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.428-1.428
TTM-1.426-1.426
YOY78.9581.503+77.455
5Y29.5951.440+28.155
10Y18.6231.371+17.252

1.3. Liquidity of Inhalerx Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Inhalerx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.73 means the company has $1.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inhalerx Ltd:

  • The MRQ is 1.731. The company is able to pay all its short-term debts. +1
  • The TTM is 1.731. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.731TTM1.7310.000
TTM1.731YOY6.316-4.586
TTM1.7315Y4.949-3.219
5Y4.94910Y5.822-0.873
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7312.787-1.056
TTM1.7312.763-1.032
YOY6.3163.488+2.828
5Y4.9493.617+1.332
10Y5.8223.514+2.308
1.3.2. Quick Ratio

Measures if Inhalerx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • A Quick Ratio of 1.67 means the company can pay off $1.67 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inhalerx Ltd:

  • The MRQ is 1.666. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.666. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.666TTM1.6660.000
TTM1.666YOY6.093-4.427
TTM1.6665Y4.832-3.165
5Y4.83210Y5.740-0.909
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6661.539+0.127
TTM1.6661.660+0.006
YOY6.0932.139+3.954
5Y4.8322.300+2.532
10Y5.7402.255+3.485

1.4. Solvency of Inhalerx Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Inhalerx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inhalerx to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.58 means that Inhalerx assets are financed with 57.8% credit (debt) and the remaining percentage (100% - 57.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Inhalerx Ltd:

  • The MRQ is 0.578. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.578. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.578TTM0.5780.000
TTM0.578YOY0.157+0.421
TTM0.5785Y0.316+0.262
5Y0.31610Y0.247+0.069
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5780.389+0.189
TTM0.5780.386+0.192
YOY0.1570.338-0.181
5Y0.3160.442-0.126
10Y0.2470.460-0.213
1.4.2. Debt to Equity Ratio

Measures if Inhalerx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • A Debt to Equity ratio of 91.5% means that company has $0.91 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inhalerx Ltd:

  • The MRQ is 0.915. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.915. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.915TTM0.9150.000
TTM0.915YOY0.187+0.728
TTM0.9155Y0.494+0.421
5Y0.49410Y0.365+0.128
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9150.559+0.356
TTM0.9150.560+0.355
YOY0.1870.478-0.291
5Y0.4940.624-0.130
10Y0.3650.674-0.309

2. Market Valuation of Inhalerx Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inhalerx generates.

  • Above 15 is considered overpriced but always compare Inhalerx to the Medical Devices industry mean.
  • A PE ratio of -3.81 means the investor is paying $-3.81 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inhalerx Ltd:

  • The EOD is -4.076. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.813. Based on the earnings, the company is expensive. -2
  • The TTM is -3.813. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.076MRQ-3.813-0.263
MRQ-3.813TTM-3.8130.000
TTM-3.813YOY-5.909+2.095
TTM-3.8135Y-7.968+4.155
5Y-7.96810Y-6.978-0.990
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.076-1.037-3.039
MRQ-3.813-1.578-2.235
TTM-3.813-2.041-1.772
YOY-5.909-2.971-2.938
5Y-7.968-2.058-5.910
10Y-6.978-1.463-5.515
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inhalerx Ltd:

  • The EOD is -2.999. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.805. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.805. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.999MRQ-2.805-0.193
MRQ-2.805TTM-2.8050.000
TTM-2.805YOY-6.166+3.361
TTM-2.8055Y-41.817+39.012
5Y-41.81710Y-28.004-13.813
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.999-1.007-1.992
MRQ-2.805-1.544-1.261
TTM-2.805-3.018+0.213
YOY-6.166-6.339+0.173
5Y-41.817-4.928-36.889
10Y-28.004-4.950-23.054
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Inhalerx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 8.27 means the investor is paying $8.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inhalerx Ltd:

  • The EOD is 8.840. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.270. Based on the equity, the company is overpriced. -1
  • The TTM is 8.270. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.840MRQ8.270+0.570
MRQ8.270TTM8.2700.000
TTM8.270YOY5.984+2.286
TTM8.2705Y10.017-1.747
5Y10.01710Y7.490+2.526
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD8.8401.987+6.853
MRQ8.2702.379+5.891
TTM8.2702.444+5.826
YOY5.9843.215+2.769
5Y10.0173.833+6.184
10Y7.4904.163+3.327
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Inhalerx Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.007-0.0070%-0.004-37%-0.002-67%0.000-1587%
Book Value Per Share--0.0040.0040%0.010-65%0.007-52%0.014-75%
Current Ratio--1.7311.7310%6.316-73%4.949-65%5.822-70%
Debt To Asset Ratio--0.5780.5780%0.157+267%0.316+83%0.247+134%
Debt To Equity Ratio--0.9150.9150%0.187+390%0.494+85%0.365+150%
Dividend Per Share----0%-0%-0%-0%
Eps---0.008-0.0080%-0.010+34%-0.009+12%-0.008+11%
Free Cash Flow Per Share---0.010-0.0100%-0.010-6%-0.006-38%-0.007-29%
Free Cash Flow To Equity Per Share---0.007-0.0070%-0.004-53%0.003-373%0.005-248%
Gross Profit Margin--1.0001.0000%1.018-2%1.025-2%1.016-2%
Intrinsic Value_10Y_max---0.045--------
Intrinsic Value_10Y_min---0.121--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.010--------
Intrinsic Value_3Y_max---0.017--------
Intrinsic Value_3Y_min---0.031--------
Intrinsic Value_5Y_max---0.027--------
Intrinsic Value_5Y_min---0.056--------
Market Cap5882777.248+6%5503243.2325503243.2320%11386020.480-52%10968533.062-50%11459555.196-52%
Net Profit Margin----0%-76.4760%-28.4520%-77.0890%
Operating Margin----0%-77.5670%-25.9950%-17.5860%
Operating Ratio----0%78.958-100%29.595-100%18.623-100%
Pb Ratio8.840+6%8.2708.2700%5.984+38%10.017-17%7.490+10%
Pe Ratio-4.076-7%-3.813-3.8130%-5.909+55%-7.968+109%-6.978+83%
Price Per Share0.031+6%0.0290.0290%0.060-52%0.058-50%0.060-52%
Price To Free Cash Flow Ratio-2.999-7%-2.805-2.8050%-6.166+120%-41.817+1391%-28.004+898%
Price To Total Gains Ratio-4.755-7%-4.448-4.4480%-14.690+230%1.131-493%-1.370-69%
Quick Ratio--1.6661.6660%6.093-73%4.832-66%5.740-71%
Return On Assets---0.915-0.9150%-0.840-8%-1.262+38%-0.929+1%
Return On Equity---1.448-1.4480%-0.997-31%-2.061+42%-1.449+0%
Total Gains Per Share---0.007-0.0070%-0.004-37%-0.002-67%0.000-1587%
Usd Book Value--426167.628426167.6280%1218528.144-65%885043.046-52%1714056.776-75%
Usd Book Value Change Per Share---0.004-0.0040%-0.003-37%-0.001-67%0.000-1587%
Usd Book Value Per Share--0.0020.0020%0.006-65%0.005-52%0.009-75%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.0050%-0.007+34%-0.005+12%-0.005+11%
Usd Free Cash Flow---1256375.144-1256375.1440%-1182481.950-6%-784047.484-38%-892424.537-29%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.006-6%-0.004-38%-0.005-29%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%-0.002-53%0.002-373%0.003-248%
Usd Market Cap3767330.550+6%3524276.9663524276.9660%7291607.515-52%7024248.573-50%7338699.147-52%
Usd Price Per Share0.020+6%0.0190.0190%0.038-52%0.037-50%0.039-52%
Usd Profit---924270.748-924270.7480%-1214585.842+31%-990699.953+7%-1001038.778+8%
Usd Revenue----0%15881.920-100%43059.856-100%97521.153-100%
Usd Total Gains Per Share---0.004-0.0040%-0.003-37%-0.001-67%0.000-1587%
 EOD+5 -3MRQTTM+0 -0YOY+6 -265Y+8 -2410Y+7 -25

3.2. Fundamental Score

Let's check the fundamental score of Inhalerx Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.076
Price to Book Ratio (EOD)Between0-18.840
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.666
Current Ratio (MRQ)Greater than11.731
Debt to Asset Ratio (MRQ)Less than10.578
Debt to Equity Ratio (MRQ)Less than10.915
Return on Equity (MRQ)Greater than0.15-1.448
Return on Assets (MRQ)Greater than0.05-0.915
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Inhalerx Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.645
Ma 20Greater thanMa 500.043
Ma 50Greater thanMa 1000.041
Ma 100Greater thanMa 2000.035
OpenGreater thanClose0.031
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Accumulated Other Comprehensive Income  -759-229-98819-969665-30439490



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets1,577
Total Liabilities911
Total Stockholder Equity997
 As reported
Total Liabilities 911
Total Stockholder Equity+ 997
Total Assets = 1,577

Assets

Total Assets1,577
Total Current Assets1,577
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 716
Net Receivables 802
Other Current Assets 59
Total Current Assets  (as reported)1,577
Total Current Assets  (calculated)1,577
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities911
Long-term Liabilities0
Total Stockholder Equity997
Total Current Liabilities
Short-term Debt 560
Accounts payable 184
Other Current Liabilities 167
Total Current Liabilities  (as reported)911
Total Current Liabilities  (calculated)911
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/- 0
Total Stockholder Equity
Common Stock14,076
Retained Earnings -13,169
Accumulated Other Comprehensive Income 90
Total Stockholder Equity (as reported)997
Total Stockholder Equity (calculated)997
+/-0
Other
Cash and Short Term Investments 716
Common Stock Shares Outstanding 189,356
Liabilities and Stockholders Equity 1,577
Net Debt -156
Net Working Capital 666
Short Long Term Debt Total 560



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
8,575
5,086
3,091
624
1,904
2,931
2,258
1,577
1,5772,2582,9311,9046243,0915,0868,575
   > Total Current Assets 
8,225
4,774
2,560
552
1,900
2,908
2,244
1,577
1,5772,2442,9081,9005522,5604,7748,225
       Cash And Cash Equivalents 
7,611
4,516
2,315
425
1,719
2,803
2,133
716
7162,1332,8031,7194252,3154,5167,611
       Net Receivables 
614
249
226
167
120
19
32
802
8023219120167226249614
       Other Current Assets 
0
10
20
89
2
1
0
59
590128920100
   > Long-term Assets 
0
0
531
72
4
23
14
0
0142347253100
       Property Plant Equipment 
27
54
96
122
0
10
0
0
00100122965427
       Goodwill 
0
0
140
0
0
0
0
0
0000014000
       Intangible Assets 
323
141
294
0
4
14
14
0
0141440294141323
       Other Assets 
0
0
0
72
0
0
0
0
000072000
> Total Liabilities 
1,262
580
408
284
580
253
355
911
9113552535802844085801,262
   > Total Current Liabilities 
1,185
554
408
284
580
253
355
911
9113552535802844085541,185
       Short-term Debt 
0
0
0
0
-85
-25
0
560
5600-25-850000
       Accounts payable 
0
118
80
68
125
73
97
184
184977312568801180
       Other Current Liabilities 
0
436
329
215
455
180
258
167
1672581804552153294360
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
00000000
       Other Liabilities 
0
26
0
0
0
0
0
0
000000260
> Total Stockholder Equity
7,313
4,507
2,683
340
1,324
2,678
1,903
997
9971,9032,6781,3243402,6834,5077,313
   Common Stock
8,018
8,018
8,243
8,243
10,556
12,901
13,928
14,076
14,07613,92812,90110,5568,2438,2438,0188,018
   Retained Earnings -13,169-11,695-9,254-7,949-7,043-4,770-3,094-705
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 0-25-969-295-101-790-4170



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-2,627
Operating Income-2,628-2,627
 
Operating Expense (+$)
Research Development1,448
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense2,6271,448
 
Net Interest Income (+$)
Interest Income0
Interest Expense-8
Other Finance Cost-8
Net Interest Income0
 
Pretax Income (+$)
Operating Income-2,628
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,647-2,608
EBIT - interestExpense = -8
-2,647
-1,435
Interest Expense8
Earnings Before Interest and Taxes (EBIT)0-2,639
Earnings Before Interest and Taxes (EBITDA)-2,628
 
After tax Income (+$)
Income Before Tax-2,647
Tax Provision-0
Net Income From Continuing Ops0-2,647
Net Income-1,443
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,627
Total Other Income/Expenses Net-200
 

Technical Analysis of Inhalerx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inhalerx. The general trend of Inhalerx is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inhalerx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inhalerx Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.037 < 0.04 < 0.04.

The bearish price targets are: 0.03 > 0.03 > 0.03.

Tweet this
Inhalerx Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inhalerx Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inhalerx Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inhalerx Ltd. The current macd is -0.00169636.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inhalerx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Inhalerx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Inhalerx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Inhalerx Ltd Daily Moving Average Convergence/Divergence (MACD) ChartInhalerx Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inhalerx Ltd. The current adx is 38.88.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Inhalerx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Inhalerx Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inhalerx Ltd. The current sar is 0.04833748.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Inhalerx Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inhalerx Ltd. The current rsi is 19.65. The current phase is Oversold in neutral market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Oversold in neutral market:
  • Trending down: The RSI is trending down. -1
Inhalerx Ltd Daily Relative Strength Index (RSI) ChartInhalerx Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inhalerx Ltd. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inhalerx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Inhalerx Ltd Daily Stochastic Oscillator ChartInhalerx Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inhalerx Ltd. The current cci is -183.50231568.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Inhalerx Ltd Daily Commodity Channel Index (CCI) ChartInhalerx Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inhalerx Ltd. The current cmo is -80.77744367.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Inhalerx Ltd Daily Chande Momentum Oscillator (CMO) ChartInhalerx Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inhalerx Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Inhalerx Ltd Daily Williams %R ChartInhalerx Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Inhalerx Ltd.

Inhalerx Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inhalerx Ltd. The current atr is 0.00138371.

Inhalerx Ltd Daily Average True Range (ATR) ChartInhalerx Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inhalerx Ltd. The current obv is -7,046,011.

Inhalerx Ltd Daily On-Balance Volume (OBV) ChartInhalerx Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inhalerx Ltd. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Inhalerx Ltd Daily Money Flow Index (MFI) ChartInhalerx Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inhalerx Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Inhalerx Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inhalerx Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.645
Ma 20Greater thanMa 500.043
Ma 50Greater thanMa 1000.041
Ma 100Greater thanMa 2000.035
OpenGreater thanClose0.031
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Inhalerx with someone you think should read this too:
  • Are you bullish or bearish on Inhalerx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inhalerx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inhalerx Ltd

I send you an email if I find something interesting about Inhalerx Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Inhalerx Ltd.

Receive notifications about Inhalerx Ltd in your mailbox!